Edwin Rock's Insider Trades & SAST Disclosures

Edwin Rock's most recent trade in GlycoMimetics Inc was a trade of 190,000 Common Stock done at an average price of $0.3 . Disclosure was reported to the exchange on June 20, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 20 Jun 2024 190,000 565,403 (1%) 0% 0.3 48,108 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 20 Jun 2024 115,000 680,403 (1%) 0% 0.3 30,717 Common Stock
GlycoMimetics Inc
Rock Edwin Chief Medical Officer 12 Jan 2024 250,000 250,000 - - Employee Stock Option (right to buy)
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 21 Sep 2023 35,000 345,000 (0%) 0% 1.4 48,300 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 21 Sep 2023 30,403 375,403 (0%) 0% 1.4 41,956 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 19 Jan 2023 244,800 244,800 - - Employee Stock Option (right to buy)
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 22 Dec 2022 110,000 310,000 (0%) 0% 2.3 247,500 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 14 Nov 2022 100,000 100,000 (0%) 0% 1.4 143,000 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 14 Nov 2022 100,000 200,000 (0%) 0% 1.7 166,000 Common Stock
GlycoMimetics Inc
Edwin Rock Chief Medical Officer 02 Sep 2022 200,000 200,000 - - Employee stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades